Centene（1CNC）株式概要センテーン・コーポレーションは、米国で保険未加入者や保険未加入の家族、営利団体にプログラムやサービスを提供するヘルスケア企業として事業を展開している。 詳細1CNC ファンダメンタル分析スノーフレーク・スコア評価5/6将来の成長3/6過去の実績0/6財務の健全性4/6配当金0/6報酬当社が推定した公正価値より70.7%で取引されている 収益は年間66.93%増加すると予測されています 同業他社や業界と比較して、良好な取引価格 リスク分析Italian市場と比較して、過去 3 か月間の株価の変動が非常に大きいすべてのリスクチェックを見る1CNC Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€50.2286.0% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-6b213b2016201920222025202620282031Revenue US$213.1bEarnings US$15.3bAdvancedSet Fair ValueView all narrativesCentene Corporation 競合他社AmplifonSymbol: BIT:AMPMarket cap: €2.4bHumanaSymbol: NYSE:HUMMarket cap: US$36.2bDiaSorinSymbol: BIT:DIAMarket cap: €3.5bElevance HealthSymbol: NYSE:ELVMarket cap: US$84.2b価格と性能株価の高値、安値、推移の概要Centene過去の株価現在の株価US$50.2252週高値US$53.6452週安値US$19.34ベータ1.061ヶ月の変化36.80%3ヶ月変化38.94%1年変化0.22%3年間の変化-13.64%5年間の変化-15.60%IPOからの変化-7.09%最新ニュースBoard Change • May 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 2 highly experienced directors. Independent Director Ken Tanji was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Apr 30Centene Corporation Updates Earnings Guidance for the Year 2026Centene Corporation updated earnings guidance for the year 2026. For the year, the Company increased 2026 GAAP Diluted EPS Guidance to greater than $2.37. The company expects total revenue from $187.5 billion to $191.5 billion.お知らせ • Apr 07Centene Corporation Announces New Executive AppointmentsCentene Corporation announced the creation of two new executive leadership positions, which will report to Chief Executive Officer Sarah London. Centene has hired Daniel Finke as Group President, Markets and Commercial, and appointed Michael Carson to Group President, Medicare and Specialty. Finke, a seasoned healthcare executive with more than two decades of experience leading and scaling complex health plan organizations across government and commercial markets, will oversee the Medicaid and Commercial segments. He joins Centene from Convey Health Solutions, where he served as Chief Executive Officer. Prior to joining Convey, he was Executive Vice President of CVS Health and President of Aetna, leading strategy and operations spanning Medicare, Medicaid, and Commercial insurance businesses. As Group President, Medicare and Specialty, Michael Carson will have expanded oversight of Centene's Medicare Advantage, Medicare Part D, Duals, and Specialty businesses. Carson's experience spans nearly three decades of healthcare leadership. Prior to joining Centene in January 2024 as CEO of its Medicare business, Wellcare, Carson served as Chief Executive Officer for Bright Healthcare and Harvard Pilgrim Health Care, as well as CareAbout, a multi-specialty, value-based care delivery organization.お知らせ • Mar 27Centene Corporation, Annual General Meeting, May 12, 2026Centene Corporation, Annual General Meeting, May 12, 2026. Location: centene plaza, 7700 forsyth boulevard, st. louis, missouri 63105, centene auditorium, United Statesお知らせ • Mar 25Centene Corporation Announces Executive Changes, Effective March 18, 2026Centene Corporation announced that effective March 18, 2026, the Board of Directors appointed Theodore Pienkos, age 44, a registered CPA, to serve as the Company's Corporate Controller and Chief Accounting Officer. Mr. Pienkos previously has served as the Company's Deputy Corporate Controller since August 2024. Prior to that, he served as Vice President of Finance & Accounting from August 2017 to August 2024, and he has held other accounting roles of increasing importance with Centene since March 2011. Before joining Centene, Mr. Pienkos served as an auditor for KPMG LLP from August 2004 to March 2011. He holds a BA and MA in Accounting from the University of Northern Iowa. Centene Corporation also announced that Kate Casso, who has been with the Company for over two decades and served as the Company's prior Corporate Controller and Chief Accounting Officer since April 2021, has been appointed Senior Vice President, Finance Operations and Innovation, effective as of March 18, 2026. In this role, Ms. Casso will devote part of her time to innovation, both enterprise-wide and within Finance, while continuing to lead Data Analytics, Medical Economics, Payment Integrity, Finance Shared Services, Financial Planning and Analysis, and other various Finance teams.お知らせ • Feb 07An undisclosed buyer signed a definitive agreement to acquire an unknown minority stake in Magellan Health, Inc. from Centene Corporation (NYSE:CNC).An undisclosed buyer signed a definitive agreement to acquire an unknown minority stake in Magellan Health, Inc. from Centene Corporation (NYSE:CNC) in December, 2025.最新情報をもっと見るRecent updatesBoard Change • May 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 2 highly experienced directors. Independent Director Ken Tanji was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Apr 30Centene Corporation Updates Earnings Guidance for the Year 2026Centene Corporation updated earnings guidance for the year 2026. For the year, the Company increased 2026 GAAP Diluted EPS Guidance to greater than $2.37. The company expects total revenue from $187.5 billion to $191.5 billion.お知らせ • Apr 07Centene Corporation Announces New Executive AppointmentsCentene Corporation announced the creation of two new executive leadership positions, which will report to Chief Executive Officer Sarah London. Centene has hired Daniel Finke as Group President, Markets and Commercial, and appointed Michael Carson to Group President, Medicare and Specialty. Finke, a seasoned healthcare executive with more than two decades of experience leading and scaling complex health plan organizations across government and commercial markets, will oversee the Medicaid and Commercial segments. He joins Centene from Convey Health Solutions, where he served as Chief Executive Officer. Prior to joining Convey, he was Executive Vice President of CVS Health and President of Aetna, leading strategy and operations spanning Medicare, Medicaid, and Commercial insurance businesses. As Group President, Medicare and Specialty, Michael Carson will have expanded oversight of Centene's Medicare Advantage, Medicare Part D, Duals, and Specialty businesses. Carson's experience spans nearly three decades of healthcare leadership. Prior to joining Centene in January 2024 as CEO of its Medicare business, Wellcare, Carson served as Chief Executive Officer for Bright Healthcare and Harvard Pilgrim Health Care, as well as CareAbout, a multi-specialty, value-based care delivery organization.お知らせ • Mar 27Centene Corporation, Annual General Meeting, May 12, 2026Centene Corporation, Annual General Meeting, May 12, 2026. Location: centene plaza, 7700 forsyth boulevard, st. louis, missouri 63105, centene auditorium, United Statesお知らせ • Mar 25Centene Corporation Announces Executive Changes, Effective March 18, 2026Centene Corporation announced that effective March 18, 2026, the Board of Directors appointed Theodore Pienkos, age 44, a registered CPA, to serve as the Company's Corporate Controller and Chief Accounting Officer. Mr. Pienkos previously has served as the Company's Deputy Corporate Controller since August 2024. Prior to that, he served as Vice President of Finance & Accounting from August 2017 to August 2024, and he has held other accounting roles of increasing importance with Centene since March 2011. Before joining Centene, Mr. Pienkos served as an auditor for KPMG LLP from August 2004 to March 2011. He holds a BA and MA in Accounting from the University of Northern Iowa. Centene Corporation also announced that Kate Casso, who has been with the Company for over two decades and served as the Company's prior Corporate Controller and Chief Accounting Officer since April 2021, has been appointed Senior Vice President, Finance Operations and Innovation, effective as of March 18, 2026. In this role, Ms. Casso will devote part of her time to innovation, both enterprise-wide and within Finance, while continuing to lead Data Analytics, Medical Economics, Payment Integrity, Finance Shared Services, Financial Planning and Analysis, and other various Finance teams.お知らせ • Feb 07An undisclosed buyer signed a definitive agreement to acquire an unknown minority stake in Magellan Health, Inc. from Centene Corporation (NYSE:CNC).An undisclosed buyer signed a definitive agreement to acquire an unknown minority stake in Magellan Health, Inc. from Centene Corporation (NYSE:CNC) in December, 2025.お知らせ • Feb 06Centene Corporation Provides Earnings Guidance for the Fiscal Year Ending December 31, 2026Centene Corporation provided earnings guidance for the fiscal year ending December 31, 2026. The Company expects its 2026 GAAP diluted EPS guidance of greater than $1.98 and Total revenues of $186.5 billion to $190.5 billion.お知らせ • Jan 02+ 3 more updatesCentene Corporation to Report Q1, 2026 Results on Apr 28, 2026Centene Corporation announced that they will report Q1, 2026 results at 8:30 AM, US Eastern Standard Time on Apr 28, 2026お知らせ • Nov 07Centene Corporation's Ambetter from Arizona Complete Health Offers Health Insurance in Arizona in 2026Centene Corporation's Ambetter from Arizona Complete Health will offer a variety of affordable health insurance plans to Arizonans in nine counties for plan year 2026. The open enrollment period for the Health Insurance Marketplace runs from Nov. 1, 2025, through Jan. 15, 2026. Enroll by Dec. 15, 2025, for coverage starting Jan. 1, 2026. Ambetter Health Solutions: Ambetter Health Solutions, Centene Corporation's off-exchange marketplace business offerings, delivers individual health insurance plans that are compatible with Individual Coverage Health Reimbursement Arrangements (ICHRAs). While not an ICHRA itself, Ambetter Health Solutions supports employers who choose to adopt this reimbursement model by providing employees with access to affordable, customizable and dependable coverage options. Available in select states, including Arizona, these plans empower individuals to choose the coverage that best fits their needs, helping employers control costs while offering greater choice and flexibility to their workforce. Ambetter Perks: Ambetter from Arizona Complete Health offers additional services to support health and financial well-being through the Ambetter Perks program for members in Arizona. This program gives members access to discounts on a variety of products and services, including wellness activities, financial tools, memberships, out-of-pocket prescription costs and over-the-counter (OTC) health items. It also includes services that promote healthy lifestyles and address social factors that impact health. The Ambetter Perks program is open to all members. Convenient Online Enrollment: Through the Ambetter from Arizona Complete Health website, people can browse and compare coverage options, determine their eligibility for financial subsidies and directly enroll in coverage -- all in one place. The platform is accessible through mobile devices, so people can enroll using smartphones. If a person is unable to complete enrollment all at once, the system will save progress and provide reminders to finish enrollment. My Health Pays: Members have access to the My Health Pays®? program, where they can earn points for practicing healthy eating habits, staying active and leading a healthy lifestyle. Through the program, members can complete health-related activities and challenges to earn up to $500 in rewards in 2026. These rewards can be used for health-related expenses such as copays and deductibles (pharmacy copays are excluded). My Health Pays also allows members to set and reach health goals at their own pace by providing seasonal suggestions for activities and guidance to help stay on track. Virtual 24/7 Care: Virtual 24/7 Care offers members a licensed provider via telehealth for members to access care for illnesses such as flu, skin conditions, ear infections, fever and respiratory infections -- all from the comfort of their home.お知らせ • Nov 04+ 1 more updateAmbetter from Peach State Health Plan Offers Health Insurance in Georgia in 2026Ambetter from Peach State Health Plan, a product offered by a Centene Corporation company, will offer a variety of affordable health insurance plans to Georgians in 149 counties for plan year 2026. The open enrollment period for the Health Insurance Marketplace runs from Nov. 1, 2025, through Jan. 15, 2026. Enroll by Dec. 15, 2025, for coverage starting Jan. 1, 2026. Ambetter from Peach State Health Plan offers its members access to quality care and convenient services. 2026 benefits and offerings include: Affordable and Reliable Coverage: Am better from Peach State Health Plan provides coverage for all essential health benefits, including preventive and wellness services, maternity and newborn care, pediatric services, mental health services, hospitalizations and prescription drug coverage. Some plans also include dental and vision coverage. Ambetter Health Solutions: Ambetter Health Solutions, Centene Corporation's off-exchange marketplace business offerings, delivers individual health insurance plans that are compatible with Individual Coverage Health Reimbursement Arrangements (ICHRAs). While not an ICHRA itself, Ambetter Health Solutions supports employers who choose to adopt this reimbursement model by providing employees with access to affordable, customizable and dependable coverage options. Available in select states, including Georgia, these plans empower individuals to choose the coverage that best fits their needs, helping employers control costs while offering greater choice and flexibility to their workforce. Ambetter Perks: Ambetter Perks: Am better Perks: Ambetter Health offers additional services to support health and financial well-being through the Ambetter Perks program for members in Georgia. This program gives members access to discounts on a variety of products and services, including wellness activities, financial tools, memberships, out-of-pocket prescription costs and over-the-counter (OTC) health items. It also includes services that promote healthy lifestyles and address social factors that impact health. The Ambetter Perks program is open to all members. Convenient Online Enrollment: Through the Ambetter from Peach State Health plan website, people can browse and compare coverage options, determine their eligibility for financial subsidies and directly enroll in coverage -- all in one place. The platform is accessible through mobile devices, so people can enroll using smartphones. If a person is unable to complete enrollment all at once, the system will save progress and provide reminders to finish enrollment. My Health Pays: Members have access to the My Health Pays®? program, where they can earn points for practicing healthy eating habits, staying active and leading a healthy lifestyle. Through the program, members can complete health-related activities and challenges to earn up to $500 in rewards in 2026. These rewards can be used for health-related expenses such as premiums, copays and deductibles (pharmacy copays are excluded). Rewards can also be used for everyday items and pharmacy copays at Walmart. My Health Pays®? also allows members to set and reach health goals at their own pace by providing seasonal suggestions for activities and guidance to help stay on track. Virtual 24/7 Care: Virtual 24/7 Care offers members a licensed provider via telehealth for members to access care for illnesses such as flu, skin conditions, ear infections, fever and respiratory infections -- all from the comfort of their home.お知らせ • Oct 31Centene Corporation Reports Impairment Charges for the Third Quarter 2025Centene Corporation reported impairment charges for the third quarter 2025. For the quarter, the company reported non-cash goodwill impairment charge of $6.7 billion.お知らせ • Oct 29Centene Corporation Updates Earnings Guidance for the Full Year 2025Centene Corporation updated earnings guidance for the full year 2025. The Company is updating its full year 2025 GAAP forecast to a diluted loss per share not to exceed $12.85.お知らせ • Sep 29Centene Corporation to Report Q3, 2025 Results on Oct 29, 2025Centene Corporation announced that they will report Q3, 2025 results at 6:00 AM, US Eastern Standard Time on Oct 29, 2025お知らせ • Aug 07Centene Corporation Stock Drop Triggers Securities Fraud Class ActionBleichmar Fonti & Auld LLP announced that a lawsuit has been filed against Centene Corporation and certain of the Company’s senior executives for potential violations of the federal securities laws. Investors have until September 8, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Centene securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned: Lunstrum v. Centene Corporation, et al., No. 25-cv-05659. Centene is a healthcare company that focuses on providing services to consumers enrolled in government-sponsored healthcare programs like Medicaid and Medicare, as well as those that purchase insurance under the Affordable Care Act from the Health Insurance Marketplace. On December 12, 2024, Centene announced financial guidance for fiscal year 2025 which the company said reflected “[s]tability in earnings power in the face of unprecedented headwinds.” Next, on February 4, 2025, Centene increased its 2025 guidance due to enrollment “overperformance.” Then, on April 25, 2025, Centene again increased 2025 guidance due to continued strong growth in enrollment and retention, while touting the “progress we are making as an organization while navigating a dynamic policy landscape.” In truth, the majority of the market that Centene serves was experiencing lower than expected enrollment growth and increased morbidity rates, or frequency of disease and illness. On July 1, 2025, Centene abruptly withdrew its previous guidance after reviewing an independent actuarial report from Wakely Consulting Group which showed that overall market growth in 22 of the 29 states Centene serves was lower than expected and that morbidity in those states was significantly higher than expected. On this news, the price of Centene stock fell $22.87 per share, or more than 40%, from $56.65 per share on July 1, 2025 to $33.78 per share on July 2, 2025.お知らせ • Jul 02Centene Corporation to Report Q2, 2025 Results on Jul 25, 2025Centene Corporation announced that they will report Q2, 2025 results on Jul 25, 2025お知らせ • Apr 25Centene Corporation Re-Iterates Earnings Guidance for the Full Year 2025Centene Corporation re-iterated earnings guidance for the full year 2025. For the year, the company expects increasing its 2025 premium and service revenues guidance range by $6.0 billion to a range of $164.0 billion to $166.0 billion to reflect the following expectations: $5.0 billion of additional Marketplace premium revenue due to outperformance in enrollment throughout the first quarter; and outperformance in the Medicare Advantage annual enrollment period resulting in $1.0 billion of additional premium revenue. The Company reiterates its 2025 GAAP diluted EPS guidance floor of greater than $6.1.お知らせ • Mar 28Centene Corporation, Annual General Meeting, May 13, 2025Centene Corporation, Annual General Meeting, May 13, 2025. Location: centene plaza, 7700 forsyth blvd, missouri 63105, st.louis United Statesお知らせ • Feb 05Centene Corporation to Report Q1, 2025 Results on Apr 25, 2025Centene Corporation announced that they will report Q1, 2025 results at 8:30 AM, Eastern Daylight on Apr 25, 2025株主還元1CNCIT HealthcareIT 市場7D2.5%-2.7%0.7%1Y0.2%-9.6%18.4%株主還元を見る業界別リターン: 1CNC過去 1 年間で-9.6 % の収益を上げたItalian Healthcare業界を上回りました。リターン対市場: 1CNCは、過去 1 年間で18.4 % のリターンを上げたItalian市場を下回りました。価格変動Is 1CNC's price volatile compared to industry and market?1CNC volatility1CNC Average Weekly Movement9.5%Healthcare Industry Average Movement5.1%Market Average Movement5.3%10% most volatile stocks in IT Market8.7%10% least volatile stocks in IT Market3.3%安定した株価: 1CNCの株価は、 Italian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 1CNCの weekly volatility ( 9% ) は過去 1 年間安定していますが、依然としてItalianの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト198461,100Sarah Londonwww.centene.comセンテーン・コーポレーションは、米国で保険未加入者や保険未加入の家族、営利団体にプログラムやサービスを提供するヘルスケア企業として事業を展開している。同社は4つのセグメントで事業を展開している：メディケイド、メディケア、コマーシャル、その他である。メディケイド事業では、貧困家庭への一時的支援、メディケイドの拡大、高齢者・盲人・障がい者・小児医療保険プログラム、長期サービス・サポート、里親ケア、メディケア・メディケイド・プランなどを提供している。メディケア部門はヘルスケア製品およびサービスも提供している。メディケア部門は特別医療、メディケアサプリメント、処方薬プランを提供している。コマーシャル部門は個人、小規模、大規模グループ向けの医療保険マーケットプレイス商品を提供している。その他のセグメントは臨床医療と薬局を運営し、視力と歯科、行動衛生、連邦政府、企業管理サービスを提供している。主治医や専門医、病院、行動衛生医、補助的プロバイダーを通じてサービスを提供している。同社は1984年に設立され、ミズーリ州セントルイスに本社を置いている。もっと見るCentene Corporation 基礎のまとめCentene の収益と売上を時価総額と比較するとどうか。1CNC 基礎統計学時価総額€24.30b収益（TTM）-€5.54b売上高(TTM)€153.37b0.2xP/Sレシオ-4.5xPER（株価収益率1CNC は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計1CNC 損益計算書（TTM）収益US$178.33b売上原価US$159.50b売上総利益US$18.83bその他の費用US$25.27b収益-US$6.44b直近の収益報告Mar 31, 2026次回決算日Jul 28, 2026一株当たり利益（EPS）-13.05グロス・マージン10.56%純利益率-3.61%有利子負債／自己資本比率76.0%1CNC の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/27 16:45終値2026/05/27 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Centene Corporation 14 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。34 アナリスト機関null nullArgus Research CompanyHua HaBairdAndrew MokBarclays31 その他のアナリストを表示
Board Change • May 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 2 highly experienced directors. Independent Director Ken Tanji was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 30Centene Corporation Updates Earnings Guidance for the Year 2026Centene Corporation updated earnings guidance for the year 2026. For the year, the Company increased 2026 GAAP Diluted EPS Guidance to greater than $2.37. The company expects total revenue from $187.5 billion to $191.5 billion.
お知らせ • Apr 07Centene Corporation Announces New Executive AppointmentsCentene Corporation announced the creation of two new executive leadership positions, which will report to Chief Executive Officer Sarah London. Centene has hired Daniel Finke as Group President, Markets and Commercial, and appointed Michael Carson to Group President, Medicare and Specialty. Finke, a seasoned healthcare executive with more than two decades of experience leading and scaling complex health plan organizations across government and commercial markets, will oversee the Medicaid and Commercial segments. He joins Centene from Convey Health Solutions, where he served as Chief Executive Officer. Prior to joining Convey, he was Executive Vice President of CVS Health and President of Aetna, leading strategy and operations spanning Medicare, Medicaid, and Commercial insurance businesses. As Group President, Medicare and Specialty, Michael Carson will have expanded oversight of Centene's Medicare Advantage, Medicare Part D, Duals, and Specialty businesses. Carson's experience spans nearly three decades of healthcare leadership. Prior to joining Centene in January 2024 as CEO of its Medicare business, Wellcare, Carson served as Chief Executive Officer for Bright Healthcare and Harvard Pilgrim Health Care, as well as CareAbout, a multi-specialty, value-based care delivery organization.
お知らせ • Mar 27Centene Corporation, Annual General Meeting, May 12, 2026Centene Corporation, Annual General Meeting, May 12, 2026. Location: centene plaza, 7700 forsyth boulevard, st. louis, missouri 63105, centene auditorium, United States
お知らせ • Mar 25Centene Corporation Announces Executive Changes, Effective March 18, 2026Centene Corporation announced that effective March 18, 2026, the Board of Directors appointed Theodore Pienkos, age 44, a registered CPA, to serve as the Company's Corporate Controller and Chief Accounting Officer. Mr. Pienkos previously has served as the Company's Deputy Corporate Controller since August 2024. Prior to that, he served as Vice President of Finance & Accounting from August 2017 to August 2024, and he has held other accounting roles of increasing importance with Centene since March 2011. Before joining Centene, Mr. Pienkos served as an auditor for KPMG LLP from August 2004 to March 2011. He holds a BA and MA in Accounting from the University of Northern Iowa. Centene Corporation also announced that Kate Casso, who has been with the Company for over two decades and served as the Company's prior Corporate Controller and Chief Accounting Officer since April 2021, has been appointed Senior Vice President, Finance Operations and Innovation, effective as of March 18, 2026. In this role, Ms. Casso will devote part of her time to innovation, both enterprise-wide and within Finance, while continuing to lead Data Analytics, Medical Economics, Payment Integrity, Finance Shared Services, Financial Planning and Analysis, and other various Finance teams.
お知らせ • Feb 07An undisclosed buyer signed a definitive agreement to acquire an unknown minority stake in Magellan Health, Inc. from Centene Corporation (NYSE:CNC).An undisclosed buyer signed a definitive agreement to acquire an unknown minority stake in Magellan Health, Inc. from Centene Corporation (NYSE:CNC) in December, 2025.
Board Change • May 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 2 highly experienced directors. Independent Director Ken Tanji was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 30Centene Corporation Updates Earnings Guidance for the Year 2026Centene Corporation updated earnings guidance for the year 2026. For the year, the Company increased 2026 GAAP Diluted EPS Guidance to greater than $2.37. The company expects total revenue from $187.5 billion to $191.5 billion.
お知らせ • Apr 07Centene Corporation Announces New Executive AppointmentsCentene Corporation announced the creation of two new executive leadership positions, which will report to Chief Executive Officer Sarah London. Centene has hired Daniel Finke as Group President, Markets and Commercial, and appointed Michael Carson to Group President, Medicare and Specialty. Finke, a seasoned healthcare executive with more than two decades of experience leading and scaling complex health plan organizations across government and commercial markets, will oversee the Medicaid and Commercial segments. He joins Centene from Convey Health Solutions, where he served as Chief Executive Officer. Prior to joining Convey, he was Executive Vice President of CVS Health and President of Aetna, leading strategy and operations spanning Medicare, Medicaid, and Commercial insurance businesses. As Group President, Medicare and Specialty, Michael Carson will have expanded oversight of Centene's Medicare Advantage, Medicare Part D, Duals, and Specialty businesses. Carson's experience spans nearly three decades of healthcare leadership. Prior to joining Centene in January 2024 as CEO of its Medicare business, Wellcare, Carson served as Chief Executive Officer for Bright Healthcare and Harvard Pilgrim Health Care, as well as CareAbout, a multi-specialty, value-based care delivery organization.
お知らせ • Mar 27Centene Corporation, Annual General Meeting, May 12, 2026Centene Corporation, Annual General Meeting, May 12, 2026. Location: centene plaza, 7700 forsyth boulevard, st. louis, missouri 63105, centene auditorium, United States
お知らせ • Mar 25Centene Corporation Announces Executive Changes, Effective March 18, 2026Centene Corporation announced that effective March 18, 2026, the Board of Directors appointed Theodore Pienkos, age 44, a registered CPA, to serve as the Company's Corporate Controller and Chief Accounting Officer. Mr. Pienkos previously has served as the Company's Deputy Corporate Controller since August 2024. Prior to that, he served as Vice President of Finance & Accounting from August 2017 to August 2024, and he has held other accounting roles of increasing importance with Centene since March 2011. Before joining Centene, Mr. Pienkos served as an auditor for KPMG LLP from August 2004 to March 2011. He holds a BA and MA in Accounting from the University of Northern Iowa. Centene Corporation also announced that Kate Casso, who has been with the Company for over two decades and served as the Company's prior Corporate Controller and Chief Accounting Officer since April 2021, has been appointed Senior Vice President, Finance Operations and Innovation, effective as of March 18, 2026. In this role, Ms. Casso will devote part of her time to innovation, both enterprise-wide and within Finance, while continuing to lead Data Analytics, Medical Economics, Payment Integrity, Finance Shared Services, Financial Planning and Analysis, and other various Finance teams.
お知らせ • Feb 07An undisclosed buyer signed a definitive agreement to acquire an unknown minority stake in Magellan Health, Inc. from Centene Corporation (NYSE:CNC).An undisclosed buyer signed a definitive agreement to acquire an unknown minority stake in Magellan Health, Inc. from Centene Corporation (NYSE:CNC) in December, 2025.
お知らせ • Feb 06Centene Corporation Provides Earnings Guidance for the Fiscal Year Ending December 31, 2026Centene Corporation provided earnings guidance for the fiscal year ending December 31, 2026. The Company expects its 2026 GAAP diluted EPS guidance of greater than $1.98 and Total revenues of $186.5 billion to $190.5 billion.
お知らせ • Jan 02+ 3 more updatesCentene Corporation to Report Q1, 2026 Results on Apr 28, 2026Centene Corporation announced that they will report Q1, 2026 results at 8:30 AM, US Eastern Standard Time on Apr 28, 2026
お知らせ • Nov 07Centene Corporation's Ambetter from Arizona Complete Health Offers Health Insurance in Arizona in 2026Centene Corporation's Ambetter from Arizona Complete Health will offer a variety of affordable health insurance plans to Arizonans in nine counties for plan year 2026. The open enrollment period for the Health Insurance Marketplace runs from Nov. 1, 2025, through Jan. 15, 2026. Enroll by Dec. 15, 2025, for coverage starting Jan. 1, 2026. Ambetter Health Solutions: Ambetter Health Solutions, Centene Corporation's off-exchange marketplace business offerings, delivers individual health insurance plans that are compatible with Individual Coverage Health Reimbursement Arrangements (ICHRAs). While not an ICHRA itself, Ambetter Health Solutions supports employers who choose to adopt this reimbursement model by providing employees with access to affordable, customizable and dependable coverage options. Available in select states, including Arizona, these plans empower individuals to choose the coverage that best fits their needs, helping employers control costs while offering greater choice and flexibility to their workforce. Ambetter Perks: Ambetter from Arizona Complete Health offers additional services to support health and financial well-being through the Ambetter Perks program for members in Arizona. This program gives members access to discounts on a variety of products and services, including wellness activities, financial tools, memberships, out-of-pocket prescription costs and over-the-counter (OTC) health items. It also includes services that promote healthy lifestyles and address social factors that impact health. The Ambetter Perks program is open to all members. Convenient Online Enrollment: Through the Ambetter from Arizona Complete Health website, people can browse and compare coverage options, determine their eligibility for financial subsidies and directly enroll in coverage -- all in one place. The platform is accessible through mobile devices, so people can enroll using smartphones. If a person is unable to complete enrollment all at once, the system will save progress and provide reminders to finish enrollment. My Health Pays: Members have access to the My Health Pays®? program, where they can earn points for practicing healthy eating habits, staying active and leading a healthy lifestyle. Through the program, members can complete health-related activities and challenges to earn up to $500 in rewards in 2026. These rewards can be used for health-related expenses such as copays and deductibles (pharmacy copays are excluded). My Health Pays also allows members to set and reach health goals at their own pace by providing seasonal suggestions for activities and guidance to help stay on track. Virtual 24/7 Care: Virtual 24/7 Care offers members a licensed provider via telehealth for members to access care for illnesses such as flu, skin conditions, ear infections, fever and respiratory infections -- all from the comfort of their home.
お知らせ • Nov 04+ 1 more updateAmbetter from Peach State Health Plan Offers Health Insurance in Georgia in 2026Ambetter from Peach State Health Plan, a product offered by a Centene Corporation company, will offer a variety of affordable health insurance plans to Georgians in 149 counties for plan year 2026. The open enrollment period for the Health Insurance Marketplace runs from Nov. 1, 2025, through Jan. 15, 2026. Enroll by Dec. 15, 2025, for coverage starting Jan. 1, 2026. Ambetter from Peach State Health Plan offers its members access to quality care and convenient services. 2026 benefits and offerings include: Affordable and Reliable Coverage: Am better from Peach State Health Plan provides coverage for all essential health benefits, including preventive and wellness services, maternity and newborn care, pediatric services, mental health services, hospitalizations and prescription drug coverage. Some plans also include dental and vision coverage. Ambetter Health Solutions: Ambetter Health Solutions, Centene Corporation's off-exchange marketplace business offerings, delivers individual health insurance plans that are compatible with Individual Coverage Health Reimbursement Arrangements (ICHRAs). While not an ICHRA itself, Ambetter Health Solutions supports employers who choose to adopt this reimbursement model by providing employees with access to affordable, customizable and dependable coverage options. Available in select states, including Georgia, these plans empower individuals to choose the coverage that best fits their needs, helping employers control costs while offering greater choice and flexibility to their workforce. Ambetter Perks: Ambetter Perks: Am better Perks: Ambetter Health offers additional services to support health and financial well-being through the Ambetter Perks program for members in Georgia. This program gives members access to discounts on a variety of products and services, including wellness activities, financial tools, memberships, out-of-pocket prescription costs and over-the-counter (OTC) health items. It also includes services that promote healthy lifestyles and address social factors that impact health. The Ambetter Perks program is open to all members. Convenient Online Enrollment: Through the Ambetter from Peach State Health plan website, people can browse and compare coverage options, determine their eligibility for financial subsidies and directly enroll in coverage -- all in one place. The platform is accessible through mobile devices, so people can enroll using smartphones. If a person is unable to complete enrollment all at once, the system will save progress and provide reminders to finish enrollment. My Health Pays: Members have access to the My Health Pays®? program, where they can earn points for practicing healthy eating habits, staying active and leading a healthy lifestyle. Through the program, members can complete health-related activities and challenges to earn up to $500 in rewards in 2026. These rewards can be used for health-related expenses such as premiums, copays and deductibles (pharmacy copays are excluded). Rewards can also be used for everyday items and pharmacy copays at Walmart. My Health Pays®? also allows members to set and reach health goals at their own pace by providing seasonal suggestions for activities and guidance to help stay on track. Virtual 24/7 Care: Virtual 24/7 Care offers members a licensed provider via telehealth for members to access care for illnesses such as flu, skin conditions, ear infections, fever and respiratory infections -- all from the comfort of their home.
お知らせ • Oct 31Centene Corporation Reports Impairment Charges for the Third Quarter 2025Centene Corporation reported impairment charges for the third quarter 2025. For the quarter, the company reported non-cash goodwill impairment charge of $6.7 billion.
お知らせ • Oct 29Centene Corporation Updates Earnings Guidance for the Full Year 2025Centene Corporation updated earnings guidance for the full year 2025. The Company is updating its full year 2025 GAAP forecast to a diluted loss per share not to exceed $12.85.
お知らせ • Sep 29Centene Corporation to Report Q3, 2025 Results on Oct 29, 2025Centene Corporation announced that they will report Q3, 2025 results at 6:00 AM, US Eastern Standard Time on Oct 29, 2025
お知らせ • Aug 07Centene Corporation Stock Drop Triggers Securities Fraud Class ActionBleichmar Fonti & Auld LLP announced that a lawsuit has been filed against Centene Corporation and certain of the Company’s senior executives for potential violations of the federal securities laws. Investors have until September 8, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Centene securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned: Lunstrum v. Centene Corporation, et al., No. 25-cv-05659. Centene is a healthcare company that focuses on providing services to consumers enrolled in government-sponsored healthcare programs like Medicaid and Medicare, as well as those that purchase insurance under the Affordable Care Act from the Health Insurance Marketplace. On December 12, 2024, Centene announced financial guidance for fiscal year 2025 which the company said reflected “[s]tability in earnings power in the face of unprecedented headwinds.” Next, on February 4, 2025, Centene increased its 2025 guidance due to enrollment “overperformance.” Then, on April 25, 2025, Centene again increased 2025 guidance due to continued strong growth in enrollment and retention, while touting the “progress we are making as an organization while navigating a dynamic policy landscape.” In truth, the majority of the market that Centene serves was experiencing lower than expected enrollment growth and increased morbidity rates, or frequency of disease and illness. On July 1, 2025, Centene abruptly withdrew its previous guidance after reviewing an independent actuarial report from Wakely Consulting Group which showed that overall market growth in 22 of the 29 states Centene serves was lower than expected and that morbidity in those states was significantly higher than expected. On this news, the price of Centene stock fell $22.87 per share, or more than 40%, from $56.65 per share on July 1, 2025 to $33.78 per share on July 2, 2025.
お知らせ • Jul 02Centene Corporation to Report Q2, 2025 Results on Jul 25, 2025Centene Corporation announced that they will report Q2, 2025 results on Jul 25, 2025
お知らせ • Apr 25Centene Corporation Re-Iterates Earnings Guidance for the Full Year 2025Centene Corporation re-iterated earnings guidance for the full year 2025. For the year, the company expects increasing its 2025 premium and service revenues guidance range by $6.0 billion to a range of $164.0 billion to $166.0 billion to reflect the following expectations: $5.0 billion of additional Marketplace premium revenue due to outperformance in enrollment throughout the first quarter; and outperformance in the Medicare Advantage annual enrollment period resulting in $1.0 billion of additional premium revenue. The Company reiterates its 2025 GAAP diluted EPS guidance floor of greater than $6.1.
お知らせ • Mar 28Centene Corporation, Annual General Meeting, May 13, 2025Centene Corporation, Annual General Meeting, May 13, 2025. Location: centene plaza, 7700 forsyth blvd, missouri 63105, st.louis United States
お知らせ • Feb 05Centene Corporation to Report Q1, 2025 Results on Apr 25, 2025Centene Corporation announced that they will report Q1, 2025 results at 8:30 AM, Eastern Daylight on Apr 25, 2025
